ConvaTec Group (OTCMKTS:CNVVY) Trading 0.2% Higher

Shares of ConvaTec Group Plc (OTCMKTS:CNVVYGet Rating) traded up 0.2% during mid-day trading on Thursday . The company traded as high as $10.72 and last traded at $10.62. 1,673 shares traded hands during trading, an increase of 26% from the average session volume of 1,326 shares. The stock had previously closed at $10.60.

A number of research firms recently issued reports on CNVVY. Royal Bank of Canada raised ConvaTec Group from an “underperform” rating to a “sector perform” rating in a research report on Wednesday, May 18th. Berenberg Bank began coverage on ConvaTec Group in a research note on Thursday, March 17th. They set a “buy” rating on the stock. Credit Suisse Group upped their price objective on ConvaTec Group from GBX 195 ($2.39) to GBX 200 ($2.45) in a research note on Thursday, May 19th. Finally, Barclays dropped their price objective on ConvaTec Group from GBX 290 ($3.55) to GBX 285 ($3.49) in a research note on Tuesday, May 31st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $247.00.

The firm has a fifty day moving average price of $10.82 and a 200-day moving average price of $10.38.

The business also recently announced a dividend, which was paid on Friday, June 3rd. Stockholders of record on Friday, April 1st were issued a dividend of $0.1325 per share. This represents a dividend yield of 1.6%. The ex-dividend date was Thursday, March 31st.

About ConvaTec Group (OTCMKTS:CNVVY)

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.

See Also

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.